US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

NEWAMSTERDAM PHARMA CO NV

35.58

+0.95002.74%

Post-market: 35.580.00000.00%17:09 EST

Volume:796.24K

Turnover:28.00M

Market Cap:4.03B

PE:-20.67

High:36.00

Open:34.38

Low:34.00

Close:34.63

52wk High:42.00

52wk Low:14.06

Shares:113.39M

Float Shares:64.72M

Volume Ratio:1.07

T/O Rate:1.23%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.7211

EPS(LYR):-1.7211

ROE:-28.29%

ROA:-17.27%

PB:5.90

PE(LYR):-20.67

Loading ...

Overview Company News Filings

NewAmsterdam Pharma (NAMS) Quarterly Loss Of US$72 Million Tests Bullish Profitability Forecasts

Simply Wall St.

NewAmsterdam Pharma (NAMS): Buy Rating on Strong PREVAIL Momentum, Broad Phase 3 Cardiovascular Program, and Solid Cash Runway

NewAmsterdam Pharma Is Maintained at Buy by Needham

Analysts Offer Insights on Healthcare Companies: NewAmsterdam Pharma Company (NAMS) and Moleculin Biotech (MBRX)

Earnings Flash (NAMS) NewAmsterdam Pharma Posts FY 2025 Revenue $22.5M versus $45.6M a Year Ago

MT Newswires Live

NewAmsterdam (NAMS) posts FY 2025 net loss of USD 203.82 million (-15.66%)

Press Release: NewAmsterdam Pharma Reports Full Year 2025 Financial Results and Provides Corporate Update

NewAmsterdam Pharma gewährt neuen Mitarbeitern Aktienoptionen im Rahmen des 2024 Inducement Plans

NewAmsterdam Pharma Executives to Join Guggenheim Emerging Outlook Biotech Summit

NewAmsterdam Pharma Chief Accounting Officer Louise Kooij Reports Disposal of Common Shares

NewAmsterdam Pharma CFO Mayur Ian Somaiya Reports Disposal of Common Shares

RBC Raises Price Target on NewAmsterdam Pharma to $47 From $44, Keeps Outperform, Speculative Risk

MT Newswires Live

NewAmsterdam Pharma Company Nv : RBC Raises Target Price to $47 From $44

THOMSON REUTERS

Should NewAmsterdam’s Multi-Indication Obicetrapib Strategy Reshape How NAMS Investors View Pipeline Concentration?

Simply Wall St.

NewAmsterdam Pharma highlights 2025 achievements, 2026 priorities

NewAmsterdam Pharma Enrolls First Patients in RUBENS Phase 3 Trial for Obicetrapib Combo in Metabolic Syndrome

NewAmsterdam Pharma Outlines 2026 Strategic Priorities Including Anticipated EMA Approval Decision, Potential European Commercial Launch, and Ongoing Phase 3 Trials for Obicetrapib and Fixed-Dose Combination Therapies

Press Release: NewAmsterdam Pharma Highlights 2025 Achievements and Outlines 2026 Strategic Priorities

NewAmsterdam Pharma Company Nv : Leerink Partners Raises Target Price to $55 From $45

THOMSON REUTERS

Newamsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/NAMS/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NAMS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NAMS\",,,,,undefined,":{"symbol":"NAMS","market":"US","secType":"STK","nameCN":"NEWAMSTERDAM PHARMA CO NV","latestPrice":35.58,"timestamp":1771621200000,"preClose":34.63,"halted":0,"volume":796235,"hourTrading":{"tag":"盘后","latestPrice":35.58,"preClose":35.58,"latestTime":"17:09 EST","volume":31045,"amount":1104579.5,"timestamp":1771625376432,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.027432861680623612,"floatShares":64720411,"shares":113390804,"eps":-1.721092,"marketStatus":"Market Closed","change":0.95,"latestTime":"02-20 16:00:00 EST","open":34.38,"high":36,"low":34,"amount":28004643.94255,"amplitude":0.057753,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.721092,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1771837200000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":34.63,"preHourTrading":{"tag":"盘前","latestPrice":34.6,"preClose":34.63,"latestTime":"09:08 EST","volume":14759,"amount":511709.73177,"timestamp":1771596511966,"change":-0.03,"changeRate":-0.000866,"amplitude":0.033497},"postHourTrading":{"tag":"盘后","latestPrice":35.58,"preClose":35.58,"latestTime":"17:09 EST","volume":31045,"amount":1104579.5,"timestamp":1771625376432,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.0682470087373723,"impliedVol":0.1938,"impliedVolPercentile":0.0319},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NAMS\",,,,,undefined,":{"symbol":"NAMS","floatShares":64720411,"roa":"-17.27%","roe":"-28.29%","lyrEps":-1.721092,"volumeRatio":1.0682470087373723,"shares":113390804,"dividePrice":0,"high":36,"amplitude":0.057753,"preClose":34.63,"low":34,"week52Low":14.06,"pbRate":"5.90","psRate":"179.28","week52High":42,"institutionHeld":0,"latestPrice":35.58,"eps":-1.721092,"divideRate":0,"volume":796235,"delay":0,"ttmEps":-1.721092,"open":34.38,"prevYearClose":35.08,"prevWeekClose":34.63,"prevMonthClose":31.12,"prevQuarterClose":35.08,"fiveDayClose":34.86,"twentyDayClose":34.81,"sixtyDayClose":38.27},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NAMS\",params:#limit:5,,,undefined,":[{"date":"2026-02-18","symbol":"NAMS","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1771405200000,"name":null,"time":"Pre-Market","dateTimestamp":1771390800000,"actualEps":null},{"market":"US","date":"2025-11-05","symbol":"NAMS","fiscalQuarterEnding":"2025/09","expectedEps":-0.38,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762318800000,"reportTimeType":"pre","actualEps":-0.41},{"market":"US","date":"2025-08-06","symbol":"NAMS","fiscalQuarterEnding":"2025/06","expectedEps":-0.52,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"pre","actualEps":-0.15}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NAMS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NAMS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4667,"buy":0.4667,"hold":0.0667,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4667,"analysts":15,"updateTime":1760936400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NAMS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NAMS","date":"2026-02-20","current":-20.672922,"percent":0.323314,"low":-27.491906,"twenty":-21.002589,"median":-11.596174,"eighty":-4.995999,"high":37.547018,"avg":-10.806482,"sd":12.241543,"marketCap":3981598863},"quantilePoints":[{"date":"2021-02-26","current":-21.012022,"twenty":-21.861751,"median":-21.551533,"eighty":-21.347758,"marketCap":146156220},{"date":"2021-03-05","current":-21.131171,"twenty":-21.83275,"median":-21.378316,"eighty":-21.121888,"marketCap":144726120},{"date":"2021-03-12","current":-21.057477,"twenty":-21.702996,"median":-21.336928,"eighty":-21.039295,"marketCap":144583110},{"date":"2021-03-19","current":-20.921405,"twenty":-21.589261,"median":-21.248455,"eighty":-20.956826,"marketCap":143153010},{"date":"2021-03-26","current":-20.670206,"twenty":-21.547958,"median":-21.13039,"eighty":-20.79868,"marketCap":140149800},{"date":"2021-04-01","current":-20.845813,"twenty":-21.531241,"median":-21.121823,"eighty":-20.817601,"marketCap":141007860},{"date":"2021-04-09","current":-21.225903,"twenty":-21.467898,"median":-21.109261,"eighty":-20.79095,"marketCap":145012140},{"date":"2021-04-16","current":-20.537749,"twenty":-21.367336,"median":-21.07922,"eighty":-20.761675,"marketCap":141436890},{"date":"2021-04-23","current":-20.315019,"twenty":-21.347758,"median":-20.984107,"eighty":-20.655391,"marketCap":140864850},{"date":"2021-04-30","current":-20.575716,"twenty":-21.338162,"median":-20.952872,"eighty":-20.552936,"marketCap":142294950},{"date":"2021-05-07","current":-20.262992,"twenty":-21.300508,"median":-20.893278,"eighty":-20.441966,"marketCap":141579900},{"date":"2021-05-14","current":-20.126121,"twenty":-21.252461,"median":-20.822297,"eighty":-20.370365,"marketCap":140435820},{"date":"2021-05-21","current":-20.063477,"twenty":-21.239434,"median":-20.785932,"eighty":-20.317104,"marketCap":140578830},{"date":"2021-05-28","current":-9.074203,"twenty":-21.215604,"median":-20.72844,"eighty":-20.270407,"marketCap":63580250},{"date":"2021-06-04","current":-9.099058,"twenty":-21.186359,"median":-20.671226,"eighty":-20.246426,"marketCap":63645797},{"date":"2021-06-11","current":-20.256213,"twenty":-21.131171,"median":-20.62297,"eighty":-20.108533,"marketCap":140864850},{"date":"2021-06-18","current":-20.772768,"twenty":-21.130859,"median":-20.59844,"eighty":-20.118,"marketCap":141579900},{"date":"2021-06-25","current":-20.724223,"twenty":-21.128116,"median":-20.62297,"eighty":-20.123197,"marketCap":142294950},{"date":"2021-07-02","current":-20.626893,"twenty":-21.122017,"median":-20.616149,"eighty":-20.125343,"marketCap":140435820},{"date":"2021-07-09","current":-20.380574,"twenty":-21.1215,"median":-20.614557,"eighty":-20.126121,"marketCap":139005720},{"date":"2021-07-16","current":-20.519425,"twenty":-21.109261,"median":-20.575716,"eighty":-20.156594,"marketCap":139291740},{"date":"2021-07-23","current":-20.512371,"twenty":-21.100962,"median":-20.537878,"eighty":-20.242284,"marketCap":138719700},{"date":"2021-07-30","current":-20.299111,"twenty":-21.057477,"median":-20.519425,"eighty":-20.242284,"marketCap":138433680},{"date":"2021-08-06","current":-20.554664,"twenty":-21.012022,"median":-20.514719,"eighty":-20.242284,"marketCap":139005720},{"date":"2021-08-13","current":-20.447221,"twenty":-20.984107,"median":-20.517067,"eighty":-20.256213,"marketCap":138719700},{"date":"2021-08-20","current":-20.697321,"twenty":-20.975132,"median":-20.51883,"eighty":-20.262992,"marketCap":139005720},{"date":"2021-08-27","current":-20.379723,"twenty":-20.972644,"median":-20.518236,"eighty":-20.265529,"marketCap":138147660},{"date":"2021-09-03","current":-20.932843,"twenty":-20.9331,"median":-20.51883,"eighty":-20.267469,"marketCap":143010000},{"date":"2021-09-10","current":-20.672351,"twenty":-20.952117,"median":-20.526525,"eighty":-20.273344,"marketCap":140578830},{"date":"2021-09-17","current":-20.788911,"twenty":-20.935877,"median":-20.538007,"eighty":-20.294251,"marketCap":140292810},{"date":"2021-09-24","current":-20.925132,"twenty":-20.932894,"median":-20.56006,"eighty":-20.301276,"marketCap":140864850},{"date":"2021-10-01","current":-21.007107,"twenty":-20.973142,"median":-20.575716,"eighty":-20.306471,"marketCap":140006790},{"date":"2021-10-08","current":-21.151111,"twenty":-21.00809,"median":-20.581853,"eighty":-20.310016,"marketCap":140721840},{"date":"2021-10-15","current":-20.992495,"twenty":-21.033503,"median":-20.614435,"eighty":-20.314138,"marketCap":140006790},{"date":"2021-10-22","current":-20.979254,"twenty":-21.015601,"median":-20.620294,"eighty":-20.319189,"marketCap":140292810},{"date":"2021-10-29","current":-21.103709,"twenty":-21.049534,"median":-20.628022,"eighty":-20.340912,"marketCap":140292810},{"date":"2021-11-05","current":-21.161406,"twenty":-21.059496,"median":-20.645111,"eighty":-20.350832,"marketCap":140578830},{"date":"2021-11-12","current":-21.337744,"twenty":-21.068902,"median":-20.670206,"eighty":-20.353037,"marketCap":140435820},{"date":"2021-11-19","current":-21.577137,"twenty":-21.091056,"median":-20.678231,"eighty":-20.353298,"marketCap":140435820},{"date":"2021-11-26","current":-21.52096,"twenty":-21.108578,"median":-20.693694,"eighty":-20.355018,"marketCap":140006790},{"date":"2021-12-03","current":-21.5525,"twenty":-21.125131,"median":-20.706276,"eighty":-20.35641,"marketCap":139863780},{"date":"2021-12-10","current":-21.569806,"twenty":-21.155229,"median":-20.729118,"eighty":-20.357488,"marketCap":140292810},{"date":"2021-12-17","current":-21.444455,"twenty":-21.18744,"median":-20.755321,"eighty":-20.360981,"marketCap":139005720},{"date":"2021-12-23","current":-21.411047,"twenty":-21.239434,"median":-20.778281,"eighty":-20.367381,"marketCap":139291740},{"date":"2021-12-31","current":-21.326314,"twenty":-21.328981,"median":-20.793694,"eighty":-20.376349,"marketCap":139434750},{"date":"2022-01-07","current":-21.496624,"twenty":-21.347524,"median":-20.831373,"eighty":-20.380063,"marketCap":140149800},{"date":"2022-01-14","current":-21.343042,"twenty":-21.350709,"median":-20.845796,"eighty":-20.384765,"marketCap":140149800},{"date":"2022-01-21","current":-21.439355,"twenty":-21.390606,"median":-20.871892,"eighty":-20.394177,"marketCap":139792275},{"date":"2022-01-28","current":-21.81807,"twenty":-21.411007,"median":-20.878577,"eighty":-20.407434,"marketCap":140006790},{"date":"2022-02-04","current":-21.195343,"twenty":-21.415476,"median":-20.901854,"eighty":-20.412214,"marketCap":139434750},{"date":"2022-02-11","current":-21.331112,"twenty":-21.429778,"median":-20.921405,"eighty":-20.419903,"marketCap":139863780},{"date":"2022-02-18","current":-21.489301,"twenty":-21.43906,"median":-20.931009,"eighty":-20.423447,"marketCap":140006790},{"date":"2022-02-25","current":-21.593859,"twenty":-21.452754,"median":-20.936467,"eighty":-20.427355,"marketCap":139863780},{"date":"2022-03-04","current":-22.31244,"twenty":-21.464918,"median":-20.972644,"eighty":-20.428933,"marketCap":140006790},{"date":"2022-03-11","current":-22.266973,"twenty":-21.496624,"median":-20.979146,"eighty":-20.432589,"marketCap":140149800},{"date":"2022-03-18","current":-22.060307,"twenty":-21.513575,"median":-20.987624,"eighty":-20.434714,"marketCap":140292810},{"date":"2022-03-25","current":-22.254443,"twenty":-21.52344,"median":-20.998804,"eighty":-20.447221,"marketCap":140578830},{"date":"2022-04-01","current":-22.154187,"twenty":-21.542769,"median":-21.012022,"eighty":-20.451813,"marketCap":140578830},{"date":"2022-04-08","current":-22.481854,"twenty":-21.567321,"median":-21.030475,"eighty":-20.452843,"marketCap":140578830},{"date":"2022-04-14","current":-22.67216,"twenty":-21.569768,"median":-21.052463,"eighty":-20.467141,"marketCap":140864850},{"date":"2022-04-22","current":-22.730966,"twenty":-21.579562,"median":-21.057477,"eighty":-20.474288,"marketCap":140864850},{"date":"2022-04-29","current":-23.274023,"twenty":-21.614609,"median":-21.067729,"eighty":-20.476303,"marketCap":141007860},{"date":"2022-05-06","current":-23.127906,"twenty":-21.66066,"median":-21.076365,"eighty":-20.478189,"marketCap":140864850},{"date":"2022-05-13","current":-23.491752,"twenty":-21.687663,"median":-21.09477,"eighty":-20.47859,"marketCap":140578830},{"date":"2022-05-20","current":-23.178757,"twenty":-21.820243,"median":-21.108122,"eighty":-20.48606,"marketCap":140578830},{"date":"2022-05-27","current":-22.893849,"twenty":-21.850993,"median":-21.120918,"eighty":-20.491024,"marketCap":141007860},{"date":"2022-06-03","current":-22.874754,"twenty":-21.920045,"median":-21.125878,"eighty":-20.495924,"marketCap":140950656},{"date":"2022-06-10","current":-23.37928,"twenty":-22.019208,"median":-21.131171,"eighty":-20.503856,"marketCap":141436890},{"date":"2022-06-17","current":-23.535903,"twenty":-22.073973,"median":-21.161634,"eighty":-20.508764,"marketCap":141579900},{"date":"2022-06-24","current":-23.228366,"twenty":-22.168168,"median":-21.177519,"eighty":-20.510788,"marketCap":140864850},{"date":"2022-07-01","current":-23.628446,"twenty":-22.205389,"median":-21.200156,"eighty":-20.514249,"marketCap":141293880},{"date":"2022-07-08","current":-24.122583,"twenty":-22.267227,"median":-21.212539,"eighty":-20.517301,"marketCap":141150870},{"date":"2022-07-15","current":-24.331277,"twenty":-22.320478,"median":-21.237179,"eighty":-20.518474,"marketCap":141150870},{"date":"2022-07-22","current":-24.090008,"twenty":-22.423227,"median":-21.257719,"eighty":-20.52015,"marketCap":141579900},{"date":"2022-07-29","current":-24.168576,"twenty":-22.534118,"median":-21.31615,"eighty":-20.524441,"marketCap":141722910},{"date":"2022-08-05","current":-4.879205,"twenty":-22.582014,"median":-21.326314,"eighty":-20.52015,"marketCap":141722910},{"date":"2022-08-12","current":-4.837995,"twenty":-22.549115,"median":-21.276097,"eighty":-20.510261,"marketCap":141865920},{"date":"2022-08-19","current":-4.945659,"twenty":-22.534118,"median":-21.248455,"eighty":-20.488701,"marketCap":142008930},{"date":"2022-08-26","current":-4.973006,"twenty":-22.502765,"median":-21.218542,"eighty":-20.475462,"marketCap":142151940},{"date":"2022-09-02","current":-4.964584,"twenty":-22.470606,"median":-21.200156,"eighty":-20.448139,"marketCap":142437960},{"date":"2022-09-09","current":-4.95567,"twenty":-22.425612,"median":-21.178962,"eighty":-20.428933,"marketCap":142296380},{"date":"2022-09-16","current":-4.974555,"twenty":-22.424465,"median":-21.161634,"eighty":-20.410452,"marketCap":142580970},{"date":"2022-09-23","current":-5.117324,"twenty":-22.418277,"median":-21.131171,"eighty":-20.379723,"marketCap":142294950},{"date":"2022-09-30","current":-5.084236,"twenty":-22.409269,"median":-21.125878,"eighty":-20.356574,"marketCap":142580970},{"date":"2022-10-07","current":-5.099691,"twenty":-22.388089,"median":-21.120336,"eighty":-20.35202,"marketCap":142580970},{"date":"2022-10-14","current":-5.125907,"twenty":-22.322487,"median":-21.105916,"eighty":-20.310612,"marketCap":142866990},{"date":"2022-10-21","current":4.123596,"twenty":-22.31244,"median":-21.088579,"eighty":-20.274813,"marketCap":143153010},{"date":"2022-10-28","current":4.07957,"twenty":-22.287254,"median":-21.074661,"eighty":-20.256213,"marketCap":143582040},{"date":"2022-11-04","current":4.09622,"twenty":-22.281341,"median":-21.06757,"eighty":-20.156594,"marketCap":143725050},{"date":"2022-11-11","current":3.835525,"twenty":-22.267291,"median":-21.05741,"eighty":-20.116823,"marketCap":140221305},{"date":"2022-11-18","current":3.965158,"twenty":-22.266973,"median":-21.047582,"eighty":-20.01593,"marketCap":145441170},{"date":"2022-11-25","current":22.070496,"twenty":-22.256949,"median":-21.02751,"eighty":-19.909786,"marketCap":812319096},{"date":"2022-12-02","current":18.678955,"twenty":-22.224077,"median":-21.009565,"eighty":-9.20741,"marketCap":693258130},{"date":"2022-12-09","current":20.55276,"twenty":-22.194292,"median":-20.992495,"eighty":-9.076373,"marketCap":766661932},{"date":"2022-12-16","current":23.284761,"twenty":-22.183606,"median":-20.985866,"eighty":-5.170387,"marketCap":873913042},{"date":"2022-12-23","current":24.514364,"twenty":-22.180369,"median":-20.979037,"eighty":-5.136784,"marketCap":921625514},{"date":"2022-12-30","current":23.500927,"twenty":-22.176953,"median":-20.972644,"eighty":-5.116761,"marketCap":889001602},{"date":"2023-01-06","current":25.713628,"twenty":-22.168168,"median":-20.939833,"eighty":-5.097544,"marketCap":965994034},{"date":"2023-01-13","current":21.766355,"twenty":-22.156426,"median":-20.931009,"eighty":-5.061828,"marketCap":833540951},{"date":"2023-01-20","current":21.475872,"twenty":-22.142244,"median":-20.923268,"eighty":-5.030111,"marketCap":823753778},{"date":"2023-01-27","current":34.556535,"twenty":-22.087638,"median":-20.91043,"eighty":-4.995999,"marketCap":1327793218},{"date":"2023-02-03","current":27.072439,"twenty":-22.055719,"median":-20.885889,"eighty":-4.981646,"marketCap":1039887195},{"date":"2023-02-10","current":27.186532,"twenty":-22.037344,"median":-20.873676,"eighty":-4.977626,"marketCap":1027653228},{"date":"2023-02-17","current":28.847843,"twenty":-22.035695,"median":-20.845796,"eighty":-4.96732,"marketCap":1088823063},{"date":"2023-02-24","current":29.876152,"twenty":-22.029478,"median":-20.834633,"eighty":-4.95567,"marketCap":1115737790},{"date":"2023-03-03","current":27.302811,"twenty":-22.012361,"median":-20.798477,"eighty":-4.893553,"marketCap":1024390836},{"date":"2023-03-10","current":28.150355,"twenty":-21.957814,"median":-20.782106,"eighty":-4.871727,"marketCap":1062723933},{"date":"2023-03-17","current":28.619298,"twenty":-21.954448,"median":-20.755321,"eighty":-4.837995,"marketCap":1079851487},{"date":"2023-03-24","current":29.32388,"twenty":-21.934194,"median":-20.729118,"eighty":3.771219,"marketCap":1116553388},{"date":"2023-03-31","current":-12.752993,"twenty":-21.910612,"median":-20.706276,"eighty":3.835525,"marketCap":1081482682},{"date":"2023-04-06","current":-12.88881,"twenty":-21.90985,"median":-20.697321,"eighty":3.835227,"marketCap":1098610236},{"date":"2023-04-14","current":-12.801571,"twenty":-21.899263,"median":-20.678231,"eighty":3.825059,"marketCap":1104319421},{"date":"2023-04-21","current":-14.947443,"twenty":-21.850993,"median":-20.670206,"eighty":3.781482,"marketCap":1279672948},{"date":"2023-04-28","current":-13.55748,"twenty":-21.838695,"median":-20.645111,"eighty":3.746421,"marketCap":1166304854},{"date":"2023-05-05","current":-13.247519,"twenty":-21.837737,"median":-20.628022,"eighty":-3.085842,"marketCap":1137758931},{"date":"2023-05-12","current":-13.196444,"twenty":-21.830658,"median":-20.620294,"eighty":-4.801486,"marketCap":1124709366},{"date":"2023-05-19","current":-11.577513,"twenty":-21.820243,"median":-20.614435,"eighty":-4.83115,"marketCap":973024741},{"date":"2023-05-26","current":-12.873913,"twenty":-21.775441,"median":-20.581853,"eighty":-4.843609,"marketCap":1077686226},{"date":"2023-06-02","current":-13.4553,"twenty":-21.758764,"median":-20.576071,"eighty":-4.84735,"marketCap":1127563965},{"date":"2023-06-09","current":-11.336689,"twenty":-21.717141,"median":-20.565455,"eighty":-4.85482,"marketCap":953400713},{"date":"2023-06-16","current":-11.670779,"twenty":-21.688764,"median":-20.543917,"eighty":-4.866541,"marketCap":995114272},{"date":"2023-06-23","current":-11.565622,"twenty":-21.678904,"median":-20.533873,"eighty":-4.872917,"marketCap":989390525},{"date":"2023-06-30","current":-11.66219,"twenty":-21.66693,"median":-20.521238,"eighty":-4.875603,"marketCap":991025881},{"date":"2023-07-07","current":-11.380237,"twenty":-21.664978,"median":-20.517651,"eighty":-4.879205,"marketCap":964860181},{"date":"2023-07-14","current":-11.034638,"twenty":-21.662538,"median":-20.509733,"eighty":-4.882597,"marketCap":964042503},{"date":"2023-07-21","current":-11.170865,"twenty":-21.660191,"median":-20.495236,"eighty":-4.893553,"marketCap":971810445},{"date":"2023-07-28","current":-11.009662,"twenty":-21.656236,"median":-20.47859,"eighty":-4.916273,"marketCap":944418228},{"date":"2023-08-04","current":-10.763767,"twenty":-21.630704,"median":-20.475882,"eighty":-4.940196,"marketCap":919887885},{"date":"2023-08-11","current":-3.964027,"twenty":-21.619037,"median":-20.452843,"eighty":-4.879205,"marketCap":906805035},{"date":"2023-08-18","current":-4.026987,"twenty":-21.613502,"median":-20.440967,"eighty":-4.848908,"marketCap":909683857},{"date":"2023-08-25","current":-4.022548,"twenty":-21.606196,"median":-20.428933,"eighty":-4.792358,"marketCap":904744397},{"date":"2023-09-01","current":-3.768342,"twenty":-21.593859,"median":-20.420865,"eighty":-4.019699,"marketCap":848763852},{"date":"2023-09-08","current":-3.73793,"twenty":-21.590181,"median":-20.408566,"eighty":-4.001992,"marketCap":830652499},{"date":"2023-09-15","current":-3.712765,"twenty":-21.579562,"median":-20.380574,"eighty":-3.942259,"marketCap":822420066},{"date":"2023-09-22","current":-3.650753,"twenty":-21.575135,"median":-20.368501,"eighty":-3.858715,"marketCap":808424930},{"date":"2023-09-29","current":-3.421608,"twenty":-21.572125,"median":-20.356574,"eighty":-3.838428,"marketCap":750797898},{"date":"2023-10-06","current":-3.012194,"twenty":-21.570144,"median":-20.353296,"eighty":-3.76226,"marketCap":658594648},{"date":"2023-10-13","current":-2.686479,"twenty":-21.569768,"median":-20.346082,"eighty":-3.707338,"marketCap":588618966},{"date":"2023-10-20","current":-2.811146,"twenty":-21.56948,"median":-20.312815,"eighty":-3.654052,"marketCap":617432482},{"date":"2023-10-27","current":-2.375367,"twenty":-21.568992,"median":-20.309123,"eighty":-3.646351,"marketCap":519466528},{"date":"2023-11-03","current":-3.917302,"twenty":-21.567321,"median":-20.299111,"eighty":-3.544741,"marketCap":863582232},{"date":"2023-11-10","current":-3.597007,"twenty":-21.566303,"median":-20.266499,"eighty":-3.604286,"marketCap":800192497},{"date":"2023-11-17","current":-3.627589,"twenty":-21.562197,"median":-20.256213,"eighty":-3.537462,"marketCap":818303850},{"date":"2023-11-24","current":-3.529793,"twenty":-21.562057,"median":-20.239654,"eighty":-3.489083,"marketCap":799369254},{"date":"2023-12-01","current":-3.547582,"twenty":-21.5525,"median":-20.141357,"eighty":-3.52171,"marketCap":803485470},{"date":"2023-12-08","current":-3.307014,"twenty":-21.542769,"median":-20.122709,"eighty":-3.489083,"marketCap":740918979},{"date":"2023-12-15","current":-3.69562,"twenty":-21.533656,"median":-20.083807,"eighty":-3.52171,"marketCap":843824392},{"date":"2023-12-22","current":-4.035423,"twenty":-21.527619,"median":-20.01593,"eighty":-3.522576,"marketCap":921209263},{"date":"2023-12-29","current":-4.090708,"twenty":-21.52655,"median":-19.978248,"eighty":-3.526906,"marketCap":940967103},{"date":"2024-01-05","current":-4.344468,"twenty":-21.525358,"median":-19.920067,"eighty":-3.533351,"marketCap":988715215},{"date":"2024-01-12","current":-6.195434,"twenty":-21.52344,"median":-19.753335,"eighty":-3.548025,"marketCap":1408569303},{"date":"2024-01-19","current":-6.4217,"twenty":-21.52344,"median":-15.556029,"eighty":-3.549796,"marketCap":1448908225},{"date":"2024-01-26","current":-8.782403,"twenty":-21.52096,"median":-14.109091,"eighty":-3.557352,"marketCap":1976607187},{"date":"2024-02-02","current":-7.600825,"twenty":-21.513689,"median":-13.749102,"eighty":-3.569428,"marketCap":1712346084},{"date":"2024-02-09","current":-7.207212,"twenty":-21.513575,"median":-13.613957,"eighty":-3.588398,"marketCap":1611087157},{"date":"2024-02-16","current":-7.247938,"twenty":-21.506276,"median":-13.555523,"eighty":-3.597007,"marketCap":1619319590},{"date":"2024-02-23","current":-8.32854,"twenty":-21.504386,"median":-13.501613,"eighty":-3.6123,"marketCap":1870809159},{"date":"2024-03-01","current":-11.523207,"twenty":-21.501535,"median":-13.4553,"eighty":-3.617449,"marketCap":2038881713},{"date":"2024-03-08","current":-10.554531,"twenty":-21.497487,"median":-13.312518,"eighty":-3.621659,"marketCap":1867487103},{"date":"2024-03-15","current":-11.064095,"twenty":-21.496624,"median":-13.247519,"eighty":-3.626597,"marketCap":1957647810},{"date":"2024-03-22","current":-11.326445,"twenty":-21.490766,"median":-13.177305,"eighty":-3.630464,"marketCap":2004067183},{"date":"2024-03-28","current":-11.452575,"twenty":-21.477499,"median":-13.148196,"eighty":-3.631217,"marketCap":2026384190},{"date":"2024-04-05","current":-10.801745,"twenty":-21.466803,"median":-12.946408,"eighty":-3.632099,"marketCap":1911228436},{"date":"2024-04-12","current":-10.055058,"twenty":-21.461539,"median":-12.894895,"eighty":-3.633023,"marketCap":1779111758},{"date":"2024-04-19","current":-9.807844,"twenty":-21.456824,"median":-12.873913,"eighty":-3.633343,"marketCap":1735370425},{"date":"2024-04-26","current":-10.816881,"twenty":-21.455182,"median":-12.8124,"eighty":-3.637723,"marketCap":1913906477},{"date":"2024-05-03","current":-11.469203,"twenty":-21.453725,"median":-12.730824,"eighty":-3.642957,"marketCap":2029326298},{"date":"2024-05-10","current":-8.594704,"twenty":-21.447775,"median":-12.51454,"eighty":-3.64496,"marketCap":1965488386},{"date":"2024-05-17","current":-7.883065,"twenty":-21.443062,"median":-12.154706,"eighty":-3.648552,"marketCap":1802746667},{"date":"2024-05-24","current":-7.51567,"twenty":-21.440467,"median":-11.944691,"eighty":-3.653227,"marketCap":1718728474},{"date":"2024-05-31","current":-7.287445,"twenty":-21.438765,"median":-11.913972,"eighty":-3.657432,"marketCap":1666536719},{"date":"2024-06-07","current":-7.712415,"twenty":-21.436028,"median":-11.820873,"eighty":-3.667469,"marketCap":1763721366},{"date":"2024-06-14","current":-7.649457,"twenty":-21.431796,"median":-11.712329,"eighty":-3.679697,"marketCap":1749323640},{"date":"2024-06-21","current":-6.779842,"twenty":-21.425982,"median":-11.674804,"eighty":-3.69138,"marketCap":1550455058},{"date":"2024-06-28","current":-7.688806,"twenty":-21.424034,"median":-11.670779,"eighty":-3.693076,"marketCap":1758322219},{"date":"2024-07-05","current":-7.869811,"twenty":-21.420068,"median":-11.629156,"eighty":-3.69699,"marketCap":1799715680},{"date":"2024-07-12","current":-8.259367,"twenty":-21.415476,"median":-11.571568,"eighty":-3.704241,"marketCap":1888801606},{"date":"2024-07-15","current":-7.818658,"twenty":-21.415058,"median":-11.565622,"eighty":-3.706013,"marketCap":1788017528},{"date":"2024-08-02","current":-6.78968,"twenty":-21.414641,"median":-11.56183,"eighty":-3.707784,"marketCap":1552704702},{"date":"2024-08-09","current":-6.633158,"twenty":-21.412151,"median":-11.523207,"eighty":-3.71219,"marketCap":1521659607},{"date":"2024-08-16","current":-6.431294,"twenty":-21.410928,"median":-11.485219,"eighty":-3.714995,"marketCap":1475351701},{"date":"2024-08-23","current":-6.486229,"twenty":-21.403699,"median":-11.452575,"eighty":-3.729351,"marketCap":1487953851},{"date":"2024-08-30","current":-6.3175,"twenty":-21.396025,"median":-11.40917,"eighty":-3.756177,"marketCap":1449247247},{"date":"2024-09-06","current":-6.35674,"twenty":-21.393924,"median":-11.355092,"eighty":-3.77086,"marketCap":1458248783},{"date":"2024-09-13","current":-6.278261,"twenty":-21.387534,"median":-11.326445,"eighty":-3.775122,"marketCap":1440245712},{"date":"2024-09-20","current":-6.301805,"twenty":-21.376871,"median":-11.275775,"eighty":-3.783142,"marketCap":1445646633},{"date":"2024-09-27","current":-6.211555,"twenty":-21.365168,"median":-11.250767,"eighty":-3.799975,"marketCap":1424943101},{"date":"2024-10-04","current":-6.894316,"twenty":-21.350709,"median":-11.235632,"eighty":-3.813963,"marketCap":1581569822},{"date":"2024-10-11","current":-6.913935,"twenty":-21.347524,"median":-11.180631,"eighty":-3.822859,"marketCap":1586070590},{"date":"2024-10-18","current":-7.467207,"twenty":-21.343075,"median":-11.167175,"eighty":-3.825993,"marketCap":1712992243},{"date":"2024-10-25","current":-7.400501,"twenty":-21.342938,"median":-11.154909,"eighty":-3.828323,"marketCap":1697689633},{"date":"2024-10-31","current":-7.063044,"twenty":-21.342346,"median":-11.153652,"eighty":-3.831162,"marketCap":1620276426},{"date":"2024-11-08","current":-10.245268,"twenty":-21.340032,"median":-11.119592,"eighty":-3.843127,"marketCap":2037947682},{"date":"2024-11-15","current":-11.597233,"twenty":-21.336418,"median":-11.153652,"eighty":-3.852751,"marketCap":2306875223},{"date":"2024-11-22","current":-9.344667,"twenty":-21.331041,"median":-11.139145,"eighty":-3.855094,"marketCap":1858803744},{"date":"2024-11-29","current":-9.219266,"twenty":-21.330759,"median":-11.119592,"eighty":-3.856223,"marketCap":1833859559},{"date":"2024-12-06","current":-8.392551,"twenty":-21.326314,"median":-11.114547,"eighty":-3.859338,"marketCap":1669412707},{"date":"2024-12-13","current":-11.652967,"twenty":-21.305987,"median":-11.115575,"eighty":-3.87719,"marketCap":2317961528},{"date":"2024-12-20","current":-11.824812,"twenty":-21.294475,"median":-11.119592,"eighty":-3.877993,"marketCap":2352144301},{"date":"2024-12-27","current":-12.182436,"twenty":-21.26507,"median":-11.153652,"eighty":-3.894887,"marketCap":2423281422},{"date":"2025-01-03","current":-13.971232,"twenty":-21.256167,"median":-11.154909,"eighty":-3.910026,"marketCap":2779101565},{"date":"2025-01-10","current":-13.750577,"twenty":-21.252461,"median":-11.164306,"eighty":-3.918163,"marketCap":2735209745},{"date":"2025-01-17","current":-12.604247,"twenty":-21.239434,"median":-11.175748,"eighty":-3.920305,"marketCap":2507186388},{"date":"2025-01-24","current":-12.485847,"twenty":-21.225631,"median":-11.191789,"eighty":-3.922976,"marketCap":2483634680},{"date":"2025-01-31","current":-11.716245,"twenty":-21.222143,"median":-11.235632,"eighty":-3.931982,"marketCap":2330548577},{"date":"2025-02-07","current":-11.355662,"twenty":-21.212096,"median":-11.250762,"eighty":-3.948487,"marketCap":2258822920},{"date":"2025-02-14","current":-10.440751,"twenty":-21.20829,"median":-11.235632,"eighty":-3.960565,"marketCap":2076832448},{"date":"2025-02-21","current":-10.225478,"twenty":-21.200156,"median":-11.183444,"eighty":-3.964027,"marketCap":2034011161},{"date":"2025-02-28","current":-9.504592,"twenty":-21.195343,"median":-11.175748,"eighty":-3.98226,"marketCap":2296290448},{"date":"2025-03-07","current":-10.681871,"twenty":-21.178962,"median":-11.164306,"eighty":-3.997428,"marketCap":2580718582},{"date":"2025-03-14","current":-10.718234,"twenty":-21.176077,"median":-11.154835,"eighty":-4.003133,"marketCap":2589504006},{"date":"2025-03-21","current":-10.940963,"twenty":-21.161863,"median":-11.124637,"eighty":-4.016201,"marketCap":2643314734},{"date":"2025-03-28","current":-10.186414,"twenty":-21.161406,"median":-11.118097,"eighty":-4.018359,"marketCap":2461017166},{"date":"2025-04-04","current":-8.181858,"twenty":-21.151111,"median":-11.108408,"eighty":-4.019699,"marketCap":1976720616},{"date":"2025-04-11","current":-6.772761,"twenty":-21.131171,"median":-11.085541,"eighty":-4.022548,"marketCap":1636285398},{"date":"2025-04-17","current":-7.286399,"twenty":-21.131171,"median":-11.049366,"eighty":-4.026099,"marketCap":1760379526},{"date":"2025-04-25","current":-7.940948,"twenty":-21.129921,"median":-11.009301,"eighty":-4.031104,"marketCap":1918517175},{"date":"2025-05-02","current":-9.10459,"twenty":-21.123639,"median":-10.998302,"eighty":-4.034765,"marketCap":2199650774},{"date":"2025-05-09","current":-11.536892,"twenty":-21.121629,"median":-10.997201,"eighty":-4.055194,"marketCap":2161528945},{"date":"2025-05-16","current":-11.205615,"twenty":-21.120569,"median":-10.998302,"eighty":-4.084594,"marketCap":2099461659},{"date":"2025-05-23","current":-10.953938,"twenty":-21.111476,"median":-11.006409,"eighty":-4.290374,"marketCap":2052307975},{"date":"2025-05-30","current":-10.564438,"twenty":-21.108578,"median":-10.998097,"eighty":-4.342797,"marketCap":1979332035},{"date":"2025-06-06","current":-11.690992,"twenty":-21.105474,"median":-11.002458,"eighty":-4.35749,"marketCap":2190400908},{"date":"2025-06-13","current":-12.601823,"twenty":-21.102061,"median":-11.009662,"eighty":-4.386985,"marketCap":2361052337},{"date":"2025-06-20","current":-10.906,"twenty":-21.096009,"median":-11.034638,"eighty":-4.422768,"marketCap":2043326321},{"date":"2025-06-27","current":-11.055808,"twenty":-21.087156,"median":-11.017754,"eighty":-4.497549,"marketCap":2071393990},{"date":"2025-07-03","current":-11.894731,"twenty":-21.083291,"median":-11.017754,"eighty":-4.606816,"marketCap":2228572938},{"date":"2025-07-11","current":-13.195061,"twenty":-21.075684,"median":-11.055808,"eighty":-4.79464,"marketCap":2472200307},{"date":"2025-07-18","current":-13.171092,"twenty":-21.071944,"median":-11.081388,"eighty":-4.810613,"marketCap":2467709480},{"date":"2025-07-25","current":-14.016008,"twenty":-21.067824,"median":-11.091761,"eighty":-4.839398,"marketCap":2626011135},{"date":"2025-08-01","current":-13.069223,"twenty":-21.06562,"median":-11.111477,"eighty":-4.845791,"marketCap":2448623465},{"date":"2025-08-08","current":-15.555229,"twenty":-21.05775,"median":-11.119592,"eighty":-4.850879,"marketCap":2577734743},{"date":"2025-08-15","current":-17.10683,"twenty":-21.05745,"median":-11.126176,"eighty":-4.861355,"marketCap":2834858287},{"date":"2025-08-22","current":-16.610684,"twenty":-21.057344,"median":-11.154761,"eighty":-4.872322,"marketCap":2752639513},{"date":"2025-08-29","current":-16.277655,"twenty":-21.055392,"median":-11.163241,"eighty":-4.875603,"marketCap":2697451569},{"date":"2025-09-05","current":-17.439859,"twenty":-21.047582,"median":-11.170454,"eighty":-4.879205,"marketCap":2890046232},{"date":"2025-09-12","current":-18.078731,"twenty":-21.03344,"median":-11.181125,"eighty":-4.882597,"marketCap":2995916982},{"date":"2025-09-19","current":-18.167086,"twenty":-21.02751,"median":-11.201038,"eighty":-4.893553,"marketCap":3010558682},{"date":"2025-09-26","current":-17.868039,"twenty":-21.012624,"median":-11.225569,"eighty":-4.916273,"marketCap":2961002160},{"date":"2025-10-03","current":-20.865303,"twenty":-21.012022,"median":-11.235632,"eighty":-4.940196,"marketCap":3457693660},{"date":"2025-10-10","current":-22.4319,"twenty":-21.03344,"median":-11.250767,"eighty":-4.945659,"marketCap":3717302256},{"date":"2025-10-17","current":-24.786892,"twenty":-21.057477,"median":-11.275775,"eighty":-4.95567,"marketCap":4107559863},{"date":"2025-10-24","current":-24.661157,"twenty":-21.072958,"median":-11.313477,"eighty":-4.962071,"marketCap":4086723598},{"date":"2025-10-31","current":-26.316108,"twenty":-21.100962,"median":-11.330122,"eighty":-4.964584,"marketCap":4360973893},{"date":"2025-11-07","current":-18.875595,"twenty":-21.108122,"median":-11.343438,"eighty":-4.966514,"marketCap":4172884368},{"date":"2025-11-14","current":-18.680224,"twenty":-21.103709,"median":-11.369961,"eighty":-4.970546,"marketCap":4129693081},{"date":"2025-11-21","current":-19.341879,"twenty":-21.100962,"median":-11.403361,"eighty":-4.973006,"marketCap":4275967218},{"date":"2025-11-28","current":-21.18323,"twenty":-21.101511,"median":-11.425388,"eighty":-4.974245,"marketCap":4683040205},{"date":"2025-12-05","current":-18.387864,"twenty":-21.101511,"median":-11.450359,"eighty":-4.976938,"marketCap":4065060323},{"date":"2025-12-12","current":-18.551996,"twenty":-21.091056,"median":-11.462665,"eighty":-4.977903,"marketCap":4101345380},{"date":"2025-12-19","current":-17.387688,"twenty":-21.085733,"median":-11.47284,"eighty":-4.980017,"marketCap":3843948255},{"date":"2025-12-26","current":-18.285282,"twenty":-21.079828,"median":-11.497644,"eighty":-4.980806,"marketCap":4042382162},{"date":"2026-01-02","current":-17.992923,"twenty":-21.075002,"median":-11.504096,"eighty":-4.981179,"marketCap":3977749404},{"date":"2026-01-09","current":-18.362219,"twenty":-21.07093,"median":-11.523207,"eighty":-4.981835,"marketCap":4059390783},{"date":"2026-01-16","current":-16.325962,"twenty":-21.067761,"median":-11.540459,"eighty":-4.982647,"marketCap":3609229291},{"date":"2026-01-23","current":-17.854437,"twenty":-21.06562,"median":-11.56138,"eighty":-4.984708,"marketCap":3947133887},{"date":"2026-01-30","current":-16.125926,"twenty":-21.05775,"median":-11.577513,"eighty":-4.992071,"marketCap":3565006877},{"date":"2026-02-06","current":-16.443931,"twenty":-21.05745,"median":-11.596174,"eighty":-4.995999,"marketCap":3635309176},{"date":"2026-02-13","current":-17.880082,"twenty":-21.024533,"median":-11.596174,"eighty":-4.995999,"marketCap":3952803427},{"date":"2026-02-20","current":-19.534974,"twenty":-21.002589,"median":-11.596174,"eighty":-4.995999,"marketCap":3981598863}],"updateTime":1771748030922},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NAMS\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2612525873","title":"NewAmsterdam Pharma (NAMS) Quarterly Loss Of US$72 Million Tests Bullish Profitability Forecasts","url":"https://stock-news.laohu8.com/highlight/detail?id=2612525873","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612525873?lang=en_us&edition=fundamental","pubTime":"2026-02-20 06:31","pubTimestamp":1771540288,"startTime":"0","endTime":"0","summary":"NewAmsterdam Pharma (NasdaqGM:NAMS) has just posted its FY 2025 numbers with Q3 revenue of US$0.3 million, a basic EPS loss of US$0.61, and net income loss of US$72.0 million, setting the tone for a year that still reflects heavy investment. The company has seen quarterly revenue move between US$0.3 million and US$29.1 million over the last six reported periods, while basic EPS has ranged from a loss of US$0.15 to a loss of US$0.93. Margins remain firmly in loss-making territory even as...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nams/newamsterdam-pharma/news/newamsterdam-pharma-nams-quarterly-loss-of-us72-million-test","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nams/newamsterdam-pharma/news/newamsterdam-pharma-nams-quarterly-loss-of-us72-million-test","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","BLSX","BK4112","BLSG","NAMS"],"gpt_icon":0},{"id":"2612640108","title":"NewAmsterdam Pharma (NAMS): Buy Rating on Strong PREVAIL Momentum, Broad Phase 3 Cardiovascular Program, and Solid Cash Runway","url":"https://stock-news.laohu8.com/highlight/detail?id=2612640108","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612640108?lang=en_us&edition=fundamental","pubTime":"2026-02-19 19:35","pubTimestamp":1771500924,"startTime":"0","endTime":"0","summary":"Analyst Joseph Pantginis of H.C. Wainwright reiterated a Buy rating on NewAmsterdam Pharma Company, retaining the price target of $52.00. Joseph Pa...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/newamsterdam-pharma-nams-buy-rating-on-strong-prevail-momentum-broad-phase-3-cardiovascular-program-and-solid-cash-runway-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/newamsterdam-pharma-nams-buy-rating-on-strong-prevail-momentum-broad-phase-3-cardiovascular-program-and-solid-cash-runway-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NAMS","CSII"],"gpt_icon":0},{"id":"2612042889","title":"NewAmsterdam Pharma Is Maintained at Buy by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2612042889","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612042889?lang=en_us&edition=fundamental","pubTime":"2026-02-19 01:44","pubTimestamp":1771436640,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NAMS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 18, 2026 12:44 ET (17:44 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NAMS"],"gpt_icon":0},{"id":"2612440091","title":"Analysts Offer Insights on Healthcare Companies: NewAmsterdam Pharma Company (NAMS) and Moleculin Biotech (MBRX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2612440091","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612440091?lang=en_us&edition=fundamental","pubTime":"2026-02-19 01:30","pubTimestamp":1771435811,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on NewAmsterdam Pharma Company (NAMS – Research Report)...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-newamsterdam-pharma-company-nams-and-moleculin-biotech-mbrx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-newamsterdam-pharma-company-nams-and-moleculin-biotech-mbrx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","NAMS","MBRX","BK4139","BK4137","LU0029874061.USD","XLV","BK4581","LABU","LU0128526141.USD","HCSG","BK4588","XBI"],"gpt_icon":0},{"id":"2612443886","title":"Earnings Flash (NAMS) NewAmsterdam Pharma Posts FY 2025 Revenue $22.5M versus $45.6M a Year Ago","url":"https://stock-news.laohu8.com/highlight/detail?id=2612443886","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612443886?lang=en_us&edition=fundamental","pubTime":"2026-02-18 20:19","pubTimestamp":1771417197,"startTime":"0","endTime":"0","summary":"Earnings Flash (NAMS) NewAmsterdam Pharma Posts FY 2025 Revenue $22.5M versus $45.6M a Year Ago","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NAMS"],"gpt_icon":0},{"id":"2612844833","title":"NewAmsterdam (NAMS) posts FY 2025 net loss of USD 203.82 million (-15.66%)","url":"https://stock-news.laohu8.com/highlight/detail?id=2612844833","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612844833?lang=en_us&edition=fundamental","pubTime":"2026-02-18 20:00","pubTimestamp":1771416052,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NewAmsterdam Pharma Company NV published the original content used to generate this news brief via GlobeNewswire  on February 18, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260218:nNDLMn4gt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU0314104364.USD","BK4112","BK4585","LU2210149790.SGD","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","LU2095319765.USD","NAMS","SG9999014013.SGD","SG9999014021.USD","NDAQ","IE00BKPKM429.USD","LU2210150020.SGD","BK4139","SG9999014005.SGD","IE00BGHQF748.EUR","SG9999014039.USD"],"gpt_icon":0},{"id":"2612448637","title":"Press Release: NewAmsterdam Pharma Reports Full Year 2025 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2612448637","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612448637?lang=en_us&edition=fundamental","pubTime":"2026-02-18 20:00","pubTimestamp":1771416000,"startTime":"0","endTime":"0","summary":"-- Phase 3 PREVAIL CVOT blinded event rate tracking in line with observed event rate in BROADWAY--. -- Topline data from RUBENS Phase 3 trial in patients with type 2 diabetes and metabolic syndrome expected by year-end 2026 --. -- $728.9 million in cash, cash equivalents and marketable securities at December 31, 2025 --. \"At the same time, we remain focused and well positioned to execute our clinical development strategy, including the advancement of obicetrapib in our three ongoing Phase 3 trials: PREVAIL, REMBRANT and RUBENS. In December 2025, we initiated the RUBENS trial, which will evaluate obicetrapib alone and in combination with ezetimibe in patients with type 2 diabetes or metabolic syndrome that require additional lowering of LDL-C despite treatment with available therapy, with topline data expected by year-end 2026. Our PREVAIL cardiovascular outcomes trial continues to progress well, where the overall blinded MACE event rate in PREVAIL through the initial 12-months was in l","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NAMS"],"gpt_icon":0},{"id":"2609511820","title":"NewAmsterdam Pharma gewährt neuen Mitarbeitern Aktienoptionen im Rahmen des 2024 Inducement Plans","url":"https://stock-news.laohu8.com/highlight/detail?id=2609511820","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609511820?lang=en_us&edition=fundamental","pubTime":"2026-02-07 05:01","pubTimestamp":1770411673,"startTime":"0","endTime":"0","summary":"NewAmsterdam Pharma Company NV hat bekannt gegeben, dass der Vergütungsausschuss des Board of Directors die Gewhrung von Aktienoptionen für insgesamt 217.000 Stammaktien an vier neue nicht-geschftsführende Mitarbeiter genehmigt hat. Die Aktienoptionen wurden gem dem 2024 Inducement Plan mit einem Ausübungspreis von 31,57 US-Dollar pro Aktie vergeben und unterliegen einer vierjhrigen Vesting-Periode.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NewAmsterdam Pharma Company NV published the original content used to generate this news brief via GlobeNewswire  on February 06, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nNDL71tKyk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","LU2210150020.SGD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","SG9999014039.USD","NDAQ","BK4139","LU2095319765.USD","BK4585","BK4588","LU2210149790.SGD","BK4112","SG9999014013.SGD","SG9999014005.SGD","SG9999014021.USD","NAMS","IE00BKPKM429.USD","IE00B3QW5Z07.USD"],"gpt_icon":0},{"id":"2608364813","title":"NewAmsterdam Pharma Executives to Join Guggenheim Emerging Outlook Biotech Summit","url":"https://stock-news.laohu8.com/highlight/detail?id=2608364813","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608364813?lang=en_us&edition=fundamental","pubTime":"2026-02-04 21:00","pubTimestamp":1770210034,"startTime":"0","endTime":"0","summary":"NewAmsterdam Pharma Company N.V. will participate in a virtual fireside chat at the Guggenheim Emerging Outlook: Biotech Summit on Wednesday, February 11, 2026, at 8:30 a.m. ET. Ian Somaiya, Chief Financial Officer, and Matthew Philippe, Executive Vice President, Head of Investor Relations, will represent the company at the event. A live webcast of the session will be available on the investor relations section of the NewAmsterdam Pharma website, with an archived replay accessible afterwards.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NewAmsterdam Pharma Company NV published the original content used to generate this news brief via GlobeNewswire  on February 04, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nNDL8XYzWG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","LU2210150020.SGD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","SG9999014039.USD","NDAQ","BK4139","LU2095319765.USD","BK4585","BK4588","LU2210149790.SGD","BK4112","SG9999014013.SGD","SG9999014005.SGD","SG9999014021.USD","NAMS","IE00BKPKM429.USD","IE00B3QW5Z07.USD"],"gpt_icon":0},{"id":"2606756610","title":"NewAmsterdam Pharma Chief Accounting Officer Louise Kooij Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2606756610","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606756610?lang=en_us&edition=fundamental","pubTime":"2026-01-28 06:39","pubTimestamp":1769553571,"startTime":"0","endTime":"0","summary":"Louise Frederika Kooij, Chief Accounting Officer of NewAmsterdam Pharma Company NV, reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NewAmsterdam Pharma Company NV published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 27, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260127:nNDL5Vvr3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"NewAmsterdam Pharma Chief Accounting Officer Louise Kooij Reports Disposal of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NAMS"],"gpt_icon":0},{"id":"2605480584","title":"NewAmsterdam Pharma CFO Mayur Ian Somaiya Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2605480584","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605480584?lang=en_us&edition=fundamental","pubTime":"2026-01-23 06:25","pubTimestamp":1769120727,"startTime":"0","endTime":"0","summary":"Mayur Ian Somaiya, Chief Financial Officer of NewAmsterdam Pharma Company NV, reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NewAmsterdam Pharma Company NV published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 22, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260122:nNDL9tfLtd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"NewAmsterdam Pharma CFO Mayur Ian Somaiya Reports Disposal of Common Shares","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAMS","BK4139"],"gpt_icon":0},{"id":"2605265101","title":"RBC Raises Price Target on NewAmsterdam Pharma to $47 From $44, Keeps Outperform, Speculative Risk","url":"https://stock-news.laohu8.com/highlight/detail?id=2605265101","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605265101?lang=en_us&edition=fundamental","pubTime":"2026-01-21 20:11","pubTimestamp":1768997518,"startTime":"0","endTime":"0","summary":"NewAmsterdam Pharma (NAMS) has an average rating of buy and mean price target of $49.33, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","NAMS"],"gpt_icon":0},{"id":"2605050621","title":"NewAmsterdam Pharma Company Nv : RBC Raises Target Price to $47 From $44","url":"https://stock-news.laohu8.com/highlight/detail?id=2605050621","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605050621?lang=en_us&edition=fundamental","pubTime":"2026-01-21 19:08","pubTimestamp":1768993727,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nFWN3YM0IQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","NAMS"],"gpt_icon":0},{"id":"2602356903","title":"Should NewAmsterdam’s Multi-Indication Obicetrapib Strategy Reshape How NAMS Investors View Pipeline Concentration?","url":"https://stock-news.laohu8.com/highlight/detail?id=2602356903","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602356903?lang=en_us&edition=fundamental","pubTime":"2026-01-12 07:18","pubTimestamp":1768173537,"startTime":"0","endTime":"0","summary":"NewAmsterdam Pharma recently outlined its late-stage plans for obicetrapib, including an expected EMA approval decision in the second half of 2026, first-patient dosing in the RUBENS Phase 3 metabolic syndrome trial, continued progress in the PREVAIL cardiovascular outcomes study, and preparations for an Alzheimer’s disease trial based on earlier biomarker data.\nThese updates give investors clearer visibility into NewAmsterdam’s pipeline evolution across cardiometabolic and neurological...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nams/newamsterdam-pharma/news/should-newamsterdams-multi-indication-obicetrapib-strategy-r","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nams/newamsterdam-pharma/news/should-newamsterdams-multi-indication-obicetrapib-strategy-r","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["NAMS","BK4211","ISBC","BK4139"],"gpt_icon":0},{"id":"2602376452","title":"NewAmsterdam Pharma highlights 2025 achievements, 2026 priorities","url":"https://stock-news.laohu8.com/highlight/detail?id=2602376452","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602376452?lang=en_us&edition=fundamental","pubTime":"2026-01-09 21:10","pubTimestamp":1767964250,"startTime":"0","endTime":"0","summary":"NewAmsterdam Pharma (NAMS) provided an update on the obicetrapib clinical development program and outlined its strategic priorities for 2026. Key 2...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/newamsterdam-pharma-highlights-2025-achievements-2026-priorities-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/newamsterdam-pharma-highlights-2025-achievements-2026-priorities-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","NAMS"],"gpt_icon":0},{"id":"2602750723","title":"NewAmsterdam Pharma Enrolls First Patients in RUBENS Phase 3 Trial for Obicetrapib Combo in Metabolic Syndrome","url":"https://stock-news.laohu8.com/highlight/detail?id=2602750723","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602750723?lang=en_us&edition=fundamental","pubTime":"2026-01-09 21:01","pubTimestamp":1767963680,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NewAmsterdam Pharma Company NV published the original content used to generate this news brief via GlobeNewswire  on January 09, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260109:nNDL9K6ZKs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","SG9999014013.SGD","LU0314104364.USD","IE00B3QW5Z07.USD","LU2095319765.USD","SG9999014005.SGD","BK4588","IE00B64PRP62.GBP","NAMS","LU2210150020.SGD","LU2210149790.SGD","SG9999014021.USD","IE00BGHQF748.EUR","NDAQ","BK4139","IE00BKPKM429.USD","BK4585","BK4112"],"gpt_icon":0},{"id":"2602376831","title":"NewAmsterdam Pharma Outlines 2026 Strategic Priorities Including Anticipated EMA Approval Decision, Potential European Commercial Launch, and Ongoing Phase 3 Trials for Obicetrapib and Fixed-Dose Combination Therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2602376831","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602376831?lang=en_us&edition=fundamental","pubTime":"2026-01-09 21:00","pubTimestamp":1767963629,"startTime":"0","endTime":"0","summary":"NewAmsterdam Pharma Outlines 2026 Strategic Priorities Including Anticipated EMA Approval Decision, Potential European Commercial Launch, and Ongoing Phase 3 Trials for Obicetrapib and Fixed-Dose Combination Therapies. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NewAmsterdam Pharma Company NV published the original content used to generate this news brief via GlobeNewswire  on January 09, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260109:nNDL3sHhbL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","IE00B3QW5Z07.USD","SG9999014021.USD","SG9999014039.USD","LU2095319765.USD","SG9999014013.SGD","LU2210149790.SGD","BK4112","NDAQ","IE00B64PRP62.GBP","LU2210150020.SGD","BK4585","BK4588","LU0314104364.USD","SG9999014005.SGD","NAMS","IE00BGHQF748.EUR","BK4139"],"gpt_icon":0},{"id":"2602376866","title":"Press Release: NewAmsterdam Pharma Highlights 2025 Achievements and Outlines 2026 Strategic Priorities","url":"https://stock-news.laohu8.com/highlight/detail?id=2602376866","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602376866?lang=en_us&edition=fundamental","pubTime":"2026-01-09 21:00","pubTimestamp":1767963600,"startTime":"0","endTime":"0","summary":"-- Phase 3 PREVAIL CVOT overall event rate tracking in line with observed rate in BROADWAY --. -- Year-end cash, cash equivalents and marketable securities balance of approximately $729 million  --. NewAmsterdam is developing obicetrapib, an oral, low-dose, once-daily, and highly selective cholesteryl ester transfer protein  inhibitor, alone or as a fixed-dose combination with ezetimibe, as preferred LDL-C lowering therapies to be used as an adjunct to statin therapy for patients at risk of cardiovascular disease with elevated LDL-C, for whom existing therapies are not sufficiently effective or well tolerated.\"As we look to 2026, we remain committed to advancing our broader clinical development strategy, which includes three Phase 3 trials, PREVAIL, REMBRANDT, and RUBENS. In addition and based on the positive data from our Alzheimer's disease  biomarker analysis from the BROADWAY trial, we are planning to start our first dedicated Alzheimer's trial in 2026. This study could further dem","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Press Release: NewAmsterdam Pharma Highlights 2025 Achievements and Outlines 2026 Strategic Priorities","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NAMS"],"gpt_icon":0},{"id":"2601233894","title":"NewAmsterdam Pharma Company Nv : Leerink Partners Raises Target Price to $55 From $45","url":"https://stock-news.laohu8.com/highlight/detail?id=2601233894","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601233894?lang=en_us&edition=fundamental","pubTime":"2026-01-06 20:18","pubTimestamp":1767701931,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nFWN3Y70J2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","NAMS"],"gpt_icon":0},{"id":"2601858692","title":"Newamsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2601858692","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601858692?lang=en_us&edition=fundamental","pubTime":"2026-01-06 06:22","pubTimestamp":1767651758,"startTime":"0","endTime":"0","summary":"NewAmsterdam Pharma Company NV ::*NEWAMSTERDAM PHARMA REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 05-JAN-202621:01:00.147 GMT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260105:nRSD3jpgjw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAMS","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":64,"code":"91000000","status":"200"}]}}